KRAS and colorectal carcinoma: On the other hand, a more recent study investigating the effects of erlotinib treatment in CRC cell lines found that there is significantly more downregulation of autophagy proteins in cells that were KRAS-mutated (HCT116) compared to those with wild-type KRAS (HKe3) [91].